Search
Search Results
##search.searchResults.foundPlural##
-
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3468PDF: 2047HTML: 7575 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3927PDF: 1730HTML: 11851Figures Haase: 239 -
THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.
10898PDF: 6531HTML: 21954 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3376PDF: 1763HTML: 1170 -
Evaluating the use of meropenem in hematologic patients with febrile neutropenia A retrospective observational single-cohort study
1298PDF: 512HTML: 155 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
811PDF: 923PDF Supp. Files: 93HTML: 255 -
TYROSINE KINASE INHIBITORS AND INTERFERON
2958PDF: 1478HTML: 3099Cover Letter: 238 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7888PDF: 2494HTML: 2121Table 1.: 251Table 2.: 261Table 3.: 243Table 4.: 238 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2550PDF: 1232HTML: 1073 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2302PDF: 1016HTML: 1985 -
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2795PDF: 1062HTML: 2394 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
1113PDF: 603HTML: 7882 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2346PDF: 925HTML: 2017Fig 1 Rossi: 223 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3769PDF: 1733HTML: 2697 -
LENALIDOMIDE IN COMBINATION WITH DEXAMETHASONE IN ELDERLY PATIENTS WITH ADVANCED, RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND RENAL FAILURE
1409PDF: 944HTML: 1299fig 1A: 213figure1B: 183 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4395PDF: 1569HTML: 472 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1808PDF: 1343HTML: 639







